Sort
40,608 grants matching “prostate cancer”
TRANSFORMATIONAL THERAPY FOR CASTRATE- RESISTANT PROSTATE CANCER
$1,323,750University Of Washington · · FY2020 · Defense Health Agency
The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center
$1,323,213Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2021 · CA
The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center
$1,323,213Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
M.D. ANDERSON CANCER CENTER PROSTATE CANCER RESEARCH PROGRAM CLINICAL CONSORTIUM AWARD
$1,323,115The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2009 · Department of the Army
Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center
$1,322,710John J Heine · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2025 · CA
ELASTOGRAPHY: CLINICAL AND BASIC SCIENCE
$1,322,527University Of Texas Hlth Sci Ctr Houston · P01 · FY2000 · CA
Comparative Mechanisms of Cancer Chemoprevention
$1,321,997Roderick H Dashwood · Oregon State University · P01 · FY2010 · CA
PLCO Trial Etiologic and Early Marker Study
$1,321,719Steven Moore · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
$1,321,621Eduardo Vilar Sanchez · University Of Tx Md Anderson Can Ctr · UG1 · FY2024 · CA
CONCURRENT GENOMIC DELETIONS IMPACT THE RESPONSE TO PARP INHIBITION IN PROSTATE CANCER
$1,320,615Brigham & Womens Hospital Inc · · FY2022 · Defense Health Agency
NEW AWARD - PROGNOSTIC AND THERAPEUTIC SIGNIFICANCE OF COP9 SIGNALOSOME SUBUNIT CSN5 IN PROSTATE CANCER, EFFECTIVE 4/1/2020, SIGNED 2/21/2020, DISTRIBUTED 2/24/2020, FAADC 2/24/2020
$1,320,286Sloan-Kettering Institute For Cancer Research · · FY2020 · Defense Health Agency
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
$1,320,090Jaydutt V Vadgama · Charles R. Drew University Of Med & Sci · U54 · FY2013 · CA
DEFINING THE ROLE OF ABSENT IN MELANOMA 1 (AIM1) IN AGGRESSIVE PROSTATE CANCER
$1,320,000Fred Hutchinson Cancer Research Center · · FY2020 · Defense Health Agency
PROSTATE CANCER RESEARCH PROGRAM IDEA DEVELOPMENT AWARD
$1,320,000Fred Hutchinson Cancer Center · · FY2022 · Defense Health Agency
TARGETING DIABETES-ASSOCIATED RADIORESISTANCE TO IMPROVE PROSTATE CANCER CONTROL AND QUALITY-OF-LIFE OUTCOMES
$1,319,487Beckman Research Institute Of The City Of Hope · · FY2025 · Defense Health Agency
CLINICAL-GRADE TUMOR AND LONGITUDINAL CELL-FREE DNA/RNA MOLECULAR PROFILING TO OPTIMIZE TREATMENT IN LETHAL NONCASTRATE PROSTATE CANCER...ENTERED ON 7/30/2019 AS FORMULA GRANT, CORRECTED ON 11/20/2019
$1,318,736Sloan-Kettering Institute For Cancer Research · · FY2019 · Defense Health Agency
Comprehensive Cancer Center of Wake Forest University
$1,318,600Abbott J Garvin · Wake Forest University Health Sciences · P30 · FY2012 · CA
Overall Critique
$1,318,190Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2016 · CA
CHARACTERIZING AND TARGETING ANDROGEN RECEPTOR PATHWAY-INDEPENDENT PROSTATE CANCER
$1,318,056Fred Hutchinson Cancer Research Center · · FY2010 · Department of Defense
Molecular mechanisms of prostate cancer initiation
$1,317,974Michael M. Shen · Columbia University Health Sciences · P01 · FY2015 · CA
Comprhensive Center of Excellence in Health Disparities
$1,317,183John H Holmes · University Of Pennsylvania · P60 · FY2016 · MD
BIOMECHANICAL COMPUTED TOMOGRAPHY FACILITATES THE DIAGNOSIS OF OSTEOPOROSIS AND FRACTURE PREDICTION IN PATIENTS WITH HIGH-RISK PROSTATE CANCER
$1,317,059Northern California Institute For Research And Education, Inc. · · FY2022 · Defense Health Agency
Center for Interventional Oncology
$1,316,258Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2021 · CA
MODELING AND TUMOR-STROMAL COTARGETING FOR LETHAL CASTRATION-RESISTANT PROSTATE CANCER METASTASES.
$1,315,097University Of Washington · · FY2021 · Defense Health Agency
Molecular Epidemiology Studies of Occupational and Environmental Exposures
$1,314,749Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA